CARDURA Tablet Ref.[7834] Active ingredients: Doxazosin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Product name and form

CARDURA 2mg Tablets.

Pharmaceutical Form

Tablets.

2mg oblong tablets marked CN2 on one side and ‘PFIZER’ on the other.

Qualitative and quantitative composition

Doxazosin mesilate: 2.43mg equivalent to 2mg doxazosin.

Excipients of known effect:

Each tablet contains 40 mg of lactose monohydrate

Each tablet contains 0.06 mg sodium.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Doxazosin

Doxazosin is a potent and selective post-junctional alpha-1-adrenoceptor antagonist. This action results in a decrease in systemic blood pressure.

List of Excipients

Lactose
Magnesium stearate
Microcrystalline cellulose
Sodium lauryl sulfate
Sodium starch glycollate

Pack sizes and marketing

Calendar packs of 28 tablets. Aluminium/PVC/PVdC blister strips, 14 tablets/strip, 2 strips in a carton box.

Marketing authorization holder

Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Marketing authorization dates and numbers

PL 00057/0277

11 October 2006

Drugs

Drug Countries
CARDURA Cyprus, Ecuador, Estonia, Hong Kong, Ireland, Italy, Lithuania, Malta, Mexico, Nigeria, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.